Featured Editorial
-
Joe Dustin: Sites Are Driving Clinical Tech Evolution
2/20/2026
At SCOPE Summit 2026, Joe Dustin shared why clinical trial sites are emerging as the next drivers of innovation. As sites digitize operations and push back against the burden of sponsor-mandated systems, new models like “bring your own technology” and seamless digital data flow aim to reduce duplication, speed startup, and improve both coordinator and patient experiences.
-
How Salk And Sabin Helped Create The Modern Clinical Trial
2/17/2026
How Jonas Salk and Albert Sabin pioneered double-blind methodology, HeLa cell assays, and IBM data processing – innovations that became the global standard for clinical trials.
-
How To Operationalize AI-Enabled eTMF Systems Under The EU AI Act (Part 2)
2/12/2026
Learn how to comply with the EU AI Act when AI is used in GCP-critical eTMF contexts in part two of this series by Donatella Ballerini.
-
How AI-Enabled eTMF Systems Are Impacted By The EU AI Act (Part 1)
2/12/2026
Learn how the EU AI Act reshapes the regulatory treatment of AI-enabled eTMF systems with consultant Donatella Ballerini.
-
Making AI Safety Routine: How Sites And Sponsors Can Continuously Monitor Clinical AI
1/29/2026
Learn why the next frontier in AI governance will involve real-time surveillance of algorithmic performance across institutions with guidance from Akshaya Bhagavathula and Michelle A. Williams.
-
How Can AI Change Computerized System Validation?
1/27/2026
Learn how AI technologies are changing the computer system validation (CSV) landscape and what you need to understand about this transformation.
-
Digital Tools Are Failing Patients: 3 Ways Clinical Supply Can Protect Data Integrity
1/16/2026
Getting drugs and devices to the doorstep is only half the battle. When digital connections fail, trials fail. Why the digital last mile needs clinical supply ownership, human-centered design, and tech support with a bedside manner.
-
Virtual Reality Endpoints Improve Measurement Of Patients' Real-World Benefit
1/12/2026
Opus Genetics CEO George Magrath, MD, discusses how the company introduced virtual reality-enabled assessments and relied on digital endpoints to better measure participants’ vision changes.
-
Can't-Miss Advice On Selecting Your First AI-Enabled Vendor
12/12/2025
Quarles & Brady's Simone Colgan Dunlap and Meghan O’Connor offer actionable guidance to help sponsor companies make informed, strategic choices in an evolving AI market.
-
The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity
12/10/2025
Discover how AI ambient listening has changed the way Mikel Daniels, DPM, MBA, and his team conduct clinical research at WeTreatFeet Podiatry.